Clinical studies recruiting near Ghent

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

An Innovative CFD-based Dosimetry and Pre-treatment Planning Platform to Support Personalized Transarterial Therapies fo
Phase N/A · University Hospital Ghent · University Hospital, Ghent · NCT07315633 International Leukemia Target Board
Phase N/A · UH Gent · Princess Maxima Center for Pediatric Oncology · NCT05270096 A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis
Phase 2 · Investigational Site Number : 0560002 · Sanofi · NCT06867094 This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · AZ Maria Middelares · Pfizer · NCT07028853 Serum Glycomics as Prognostic and Diagnostic Biomarkers of Disease Recurrence in Liver Transplant Recipients With Hepato
Phase N/A · Ghent University Hospital · University Hospital, Ghent · NCT05866783 Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Phase 3 · Universitair Ziekenhuis Gent · Princess Maxima Center for Pediatric Oncology · NCT05327894 Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease
Phase 2/Phase 3 · AZ Maria Middelares · Bristol-Myers Squibb · NCT07106762 Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · AZ Maria Middelares-IKG ( Site 0903) · Merck Sharp & Dohme LLC · NCT06393374 A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease
Phase 3 · Site BE32004 · Astellas Pharma Global Development, Inc. · NCT05970172 A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Gr
Phase 2 · AZ Maria Middelares /ID# 272186 · AbbVie · NCT06682988 The DRAGON 2 Trial
NA · UZ Gent · Maastricht University · NCT05428735 PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease
Phase 2 · Az Maria Middelares Gent · Boehringer Ingelheim · NCT07355296 Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Phase 3 · Universitair Ziekenhuis Gent · PedAL BCU, LLC · NCT05183035 Erectile Aid Use in Post-phalloplasty and Post-metoidioplasty Transgender Patients
Phase N/A · Department of Urology, University Hospital Ghent · University Hospital, Ghent · NCT06639763 NovaSure Study: Endometrial Ablation in Women With Heavy Menstrual Bleeding
NA · Ghent University Hospital · University Hospital, Ghent · NCT05856838 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Algemeen Ziekenhuis Sint Lucas · Amgen · NCT07037433 A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
Phase 2 · AZ Maria Middelares · Eli Lilly and Company · NCT07483099 Diagnostic Accuracy of the Stepped Screening Protocol and Its Screening Tools in the Perinatal Period.
Phase N/A · AZ St Lucas · University Hospital, Ghent · NCT05961306 Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Phase 3 · Clinical Study Site · Summit Therapeutics · NCT07228832 Timing of Soft Tissue Grafting Following Immediate Implant Placement
NA · Ghent University · University Ghent · NCT05537545 A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintena
Phase 3 · UZ Gent ( Site 0406) · Merck Sharp & Dohme LLC · NCT07216703 LEOPARD Prospective Validation Cohort 1
Phase N/A · Department of Gastroenterology and Hepatology Universitair Z · Assistance Publique - Hôpitaux de Paris · NCT06723275 Co-creation of Tools for Children and Adolescents with Suicidal Thoughts And/or Behaviour
NA · Flemish Centre of Expertise in Suicide Prevention, Ghent Uni · University Ghent · NCT06776328 Mosunetuzumab-Lenalidomide Versus Investigator Choices in Patients With Relapsed or Refractory Marginal Zone Lymphoma
Phase 3 · UNIVERSITAIR ZIEKENHUIS GENT - Service Hématologie · The Lymphoma Academic Research Organisation · NCT06006117 A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary
Phase N/A · Az Sint Lucas · Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company · NCT06686615 A Prospective Randomised Study of Treatment Selection Based on Epigenetic Markers Versus Standard of Care Treatment Sele
NA · AZ Maria Middelares · Alimentiv Inc. · NCT07363044 A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Phase 3 · Ghent University Hospital · Janssen Research & Development, LLC · NCT07499232 A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Child
Phase 3 · UZ Gent - Pediatric Cardiology · Bayer · NCT07192952 Effect of IMT in Patients After Acute Exacerbations of COPD
NA · AZ Maria Middelares · KU Leuven · NCT07213128 A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in
Phase N/A · AZ Sint Lucas (Sint Lucas) · Hoffmann-La Roche · NCT07284121

Look up another city

Look up another condition